Publications by authors named "Camille Britton-Rivet"

Claim this Profile
E
Evolution of the tumor immune landscape during treatment with tebentafusp, a T cell receptor-CD3 bispecific.
Joseph J Sacco, Peter Kirk, Emma Leach, Alexander N Shoushtari, Richard D Carvajal, Camille Britton-Rivet

Cell Rep Med· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-affinity T cell receptor ImmTAC® bispecific efficiently redirects T cells to kill tumor cells expressing the cancer-testis antigen PRAME.
Ana R Ribeiro, Camille Britton-Rivet, Laura Collins, Ricardo J Carreira, Sylvie Moureau

Immunother Adv· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An HLA-E-targeted TCR bispecific molecule redirects T cell immunity against Mycobacterium tuberculosis.
Rachel L Paterson, Marco P La Manna, Victoria Arena De Souza, Andrew Walker, Dawn Gibbs-Howe, Camille Britton-Rivet

Proc Natl Acad Sci U S A· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis